Cargando…

Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman

We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were n...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Kosuke, Hamatani, Yasuhiro, Moriyoshi, Koki, Iguchi, Moritake, Masunaga, Nobutoyo, Terashima, Mariko, Abe, Mitsuru, Sasahashi, Nozomu, Akao, Masaharu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053174/
https://www.ncbi.nlm.nih.gov/pubmed/36417910
http://dx.doi.org/10.1002/ehf2.14252
_version_ 1785015349699149824
author Kobayashi, Kosuke
Hamatani, Yasuhiro
Moriyoshi, Koki
Iguchi, Moritake
Masunaga, Nobutoyo
Terashima, Mariko
Abe, Mitsuru
Sasahashi, Nozomu
Akao, Masaharu
author_facet Kobayashi, Kosuke
Hamatani, Yasuhiro
Moriyoshi, Koki
Iguchi, Moritake
Masunaga, Nobutoyo
Terashima, Mariko
Abe, Mitsuru
Sasahashi, Nozomu
Akao, Masaharu
author_sort Kobayashi, Kosuke
collection PubMed
description We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were noted. We also found the multiple organ damage, including mucocutaneous, gastrointestinal, and neurologic systems. In addition, we revealed the positive results for anti‐nucleocapsid SARS‐CoV‐2 IgG, albeit negative for SARS‐CoV‐2 polymerase chain reaction testing, suggesting the prior asymptomatic Covid‐19 infection. We finally diagnosed her as multisystem inflammatory syndrome after vaccination. Of note, we obtained myocardial specimen from the patients and demonstrated the lymphohistiocytic myocarditis, which is a rare form of myocarditis.
format Online
Article
Text
id pubmed-10053174
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100531742023-03-30 Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman Kobayashi, Kosuke Hamatani, Yasuhiro Moriyoshi, Koki Iguchi, Moritake Masunaga, Nobutoyo Terashima, Mariko Abe, Mitsuru Sasahashi, Nozomu Akao, Masaharu ESC Heart Fail Case Reports We describe a 51‐year‐old otherwise healthy woman hospitalized for hypotension, fever, and weakness 4 days after the second‐dose Covid‐19 mRNA vaccine. Elevated inflammatory markers, natriuretic peptide levels and troponin levels, and slightly reduced left ventricular ejection fraction of 50% were noted. We also found the multiple organ damage, including mucocutaneous, gastrointestinal, and neurologic systems. In addition, we revealed the positive results for anti‐nucleocapsid SARS‐CoV‐2 IgG, albeit negative for SARS‐CoV‐2 polymerase chain reaction testing, suggesting the prior asymptomatic Covid‐19 infection. We finally diagnosed her as multisystem inflammatory syndrome after vaccination. Of note, we obtained myocardial specimen from the patients and demonstrated the lymphohistiocytic myocarditis, which is a rare form of myocarditis. John Wiley and Sons Inc. 2022-11-23 /pmc/articles/PMC10053174/ /pubmed/36417910 http://dx.doi.org/10.1002/ehf2.14252 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Kobayashi, Kosuke
Hamatani, Yasuhiro
Moriyoshi, Koki
Iguchi, Moritake
Masunaga, Nobutoyo
Terashima, Mariko
Abe, Mitsuru
Sasahashi, Nozomu
Akao, Masaharu
Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title_full Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title_fullStr Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title_full_unstemmed Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title_short Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
title_sort multisystem inflammatory syndrome and lymphohistiocytic myocarditis after covid‐19 vaccine in a middle‐aged woman
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053174/
https://www.ncbi.nlm.nih.gov/pubmed/36417910
http://dx.doi.org/10.1002/ehf2.14252
work_keys_str_mv AT kobayashikosuke multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT hamataniyasuhiro multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT moriyoshikoki multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT iguchimoritake multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT masunaganobutoyo multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT terashimamariko multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT abemitsuru multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT sasahashinozomu multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman
AT akaomasaharu multisysteminflammatorysyndromeandlymphohistiocyticmyocarditisaftercovid19vaccineinamiddleagedwoman